132 related articles for article (PubMed ID: 14642697)
1. Nebivolol and its 4-keto derivative increase nitric oxide in endothelial cells by reducing its oxidative inactivation.
Cominacini L; Fratta Pasini A; Garbin U; Nava C; Davoli A; Criscuoli M; Crea A; Sawamura T; Lo Cascio V
J Am Coll Cardiol; 2003 Nov; 42(10):1838-44. PubMed ID: 14642697
[TBL] [Abstract][Full Text] [Related]
2. Nebivolol decreases oxidative stress in essential hypertensive patients and increases nitric oxide by reducing its oxidative inactivation.
Fratta Pasini A; Garbin U; Nava MC; Stranieri C; Davoli A; Sawamura T; Lo Cascio V; Cominacini L
J Hypertens; 2005 Mar; 23(3):589-96. PubMed ID: 15716701
[TBL] [Abstract][Full Text] [Related]
3. The platelet-endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells.
Cominacini L; Fratta Pasini A; Garbin U; Pastorino A; Rigoni A; Nava C; Davoli A; Lo Cascio V; Sawamura T
J Am Coll Cardiol; 2003 Feb; 41(3):499-507. PubMed ID: 12575983
[TBL] [Abstract][Full Text] [Related]
4. Effect of DL-nebivolol, its enantiomers and metabolites on the intracellular production of superoxide and nitric oxide in human endothelial cells.
Evangelista S; Garbin U; Pasini AF; Stranieri C; Boccioletti V; Cominacini L
Pharmacol Res; 2007 Apr; 55(4):303-9. PubMed ID: 17280840
[TBL] [Abstract][Full Text] [Related]
5. The binding of oxidized low density lipoprotein (ox-LDL) to ox-LDL receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells through an increased production of superoxide.
Cominacini L; Rigoni A; Pasini AF; Garbin U; Davoli A; Campagnola M; Pastorino AM; Lo Cascio V; Sawamura T
J Biol Chem; 2001 Apr; 276(17):13750-5. PubMed ID: 11278710
[TBL] [Abstract][Full Text] [Related]
6. Nebivolol prevents vascular NOS III uncoupling in experimental hyperlipidemia and inhibits NADPH oxidase activity in inflammatory cells.
Mollnau H; Schulz E; Daiber A; Baldus S; Oelze M; August M; Wendt M; Walter U; Geiger C; Agrawal R; Kleschyov AL; Meinertz T; Münzel T
Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):615-21. PubMed ID: 12692005
[TBL] [Abstract][Full Text] [Related]
7. Klotho ameliorates oxidized low density lipoprotein (ox-LDL)-induced oxidative stress via regulating LOX-1 and PI3K/Akt/eNOS pathways.
Yao Y; Wang Y; Zhang Y; Liu C
Lipids Health Dis; 2017 Apr; 16(1):77. PubMed ID: 28407763
[TBL] [Abstract][Full Text] [Related]
8. Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species.
Cominacini L; Pasini AF; Garbin U; Davoli A; Tosetti ML; Campagnola M; Rigoni A; Pastorino AM; Lo Cascio V; Sawamura T
J Biol Chem; 2000 Apr; 275(17):12633-8. PubMed ID: 10777555
[TBL] [Abstract][Full Text] [Related]
9. Nitric-oxide-mediated relaxations in salt-induced hypertension: effect of chronic beta1 -selective receptor blockade.
Cosentino F; Bonetti S; Rehorik R; Eto M; Werner-Felmayer G; Volpe M; Lüscher TF
J Hypertens; 2002 Mar; 20(3):421-8. PubMed ID: 11875309
[TBL] [Abstract][Full Text] [Related]
10. Nebivolol reduces nitroxidative stress and restores nitric oxide bioavailability in endothelium of black Americans.
Mason RP; Kalinowski L; Jacob RF; Jacoby AM; Malinski T
Circulation; 2005 Dec; 112(24):3795-801. PubMed ID: 16330685
[TBL] [Abstract][Full Text] [Related]
11. Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated rats.
Oelze M; Daiber A; Brandes RP; Hortmann M; Wenzel P; Hink U; Schulz E; Mollnau H; von Sandersleben A; Kleschyov AL; Mülsch A; Li H; Förstermann U; Münzel T
Hypertension; 2006 Oct; 48(4):677-84. PubMed ID: 16940222
[TBL] [Abstract][Full Text] [Related]
12. Effects of nebivolol on endothelial gene expression during oxidative stress in human umbilical vein endothelial cells.
Garbin U; Fratta Pasini A; Stranieri C; Manfro S; Mozzini C; Boccioletti V; Pasini A; Cominacini M; Evangelista S; Cominacini L
Mediators Inflamm; 2008; 2008():367590. PubMed ID: 18437228
[TBL] [Abstract][Full Text] [Related]
13. Effect of carvedilol and nebivolol on oxidative stress-related parameters and endothelial function in patients with essential hypertension.
Zepeda RJ; Castillo R; Rodrigo R; Prieto JC; Aramburu I; Brugere S; Galdames K; Noriega V; Miranda HF
Basic Clin Pharmacol Toxicol; 2012 Nov; 111(5):309-16. PubMed ID: 22703478
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular protective effects of nebivolol in Zucker diabetic fatty rats.
Toblli J; Cao G; Rivas C; Munoz M; Giani J; Dominici F; Angerosa M
J Hypertens; 2010 May; 28(5):1007-19. PubMed ID: 20411618
[TBL] [Abstract][Full Text] [Related]
15. Inositol phosphate metabolism and nitric-oxide synthase activity in endothelial cells are involved in the vasorelaxant activity of nebivolol.
Parenti A; Filippi S; Amerini S; Granger HJ; Fazzini A; Ledda F
J Pharmacol Exp Ther; 2000 Feb; 292(2):698-703. PubMed ID: 10640308
[TBL] [Abstract][Full Text] [Related]
16. Nebivolol: a third-generation beta-blocker that augments vascular nitric oxide release: endothelial beta(2)-adrenergic receptor-mediated nitric oxide production.
Broeders MA; Doevendans PA; Bekkers BC; Bronsaer R; van Gorsel E; Heemskerk JW; Egbrink MG; van Breda E; Reneman RS; van Der Zee R
Circulation; 2000 Aug; 102(6):677-84. PubMed ID: 10931809
[TBL] [Abstract][Full Text] [Related]
17. Effect of nebivolol on endothelial nitric oxide and peroxynitrite release in hypertensive animals: Role of antioxidant activity.
Mason RP; Kubant R; Jacob RF; Walter MF; Boychuk B; Malinski T
J Cardiovasc Pharmacol; 2006 Jul; 48(1):862-9. PubMed ID: 16891916
[TBL] [Abstract][Full Text] [Related]
18. Oxidized low density lipoprotein receptor-1 mediates oxidized low density lipoprotein-induced apoptosis in human umbilical vein endothelial cells: role of reactive oxygen species.
Chen XP; Xun KL; Wu Q; Zhang TT; Shi JS; Du GH
Vascul Pharmacol; 2007 Jul; 47(1):1-9. PubMed ID: 17433786
[TBL] [Abstract][Full Text] [Related]
19. Nebivolol: an endothelium-friendly selective β1-adrenoceptor blocker.
Gao Y; Vanhoutte PM
J Cardiovasc Pharmacol; 2012 Jan; 59(1):16-21. PubMed ID: 21283024
[TBL] [Abstract][Full Text] [Related]
20. Nebivolol dilates human penile arteries and reverses erectile dysfunction in diabetic rats through enhancement of nitric oxide signaling.
Angulo J; Wright HM; Cuevas P; González-Corrochano R; Fernández A; Cuevas B; La Fuente JM; Gupta S; Sáenz de Tejada I
J Sex Med; 2010 Aug; 7(8):2681-97. PubMed ID: 20214719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
